Effect of pre-medication on gastroduodenoscopy in isoflurane-anesthetized cats

The pre‐medicant chosen may influence the ease with which gastroduodenoscopy (GD) is performed. The purpose of this study was to evaluate the relative ease of GD in cats under ketamine and isoflurane anesthesia after IM injection of hydromorphone (H, 0.1 mg kg^?1), hydromorphone plus glycopyrrolate (HG, 0.1 mg kg^?1 (H), 0.01 mg kg^?1 (G)), medetomidine (M, 0.03 mg kg^?1), or butorphanol (B, 0.4 mg kg^?1). Eight cats were assigned randomly to receive each treatment in a cross‐over design with at least 7 days between treatments. Twenty minutes after pre‐medication, medetomidine produced greater (p = 0.001) sedation than the other treatments when assessed, using a subjective ordinal scale. The cats were injected with ketamine (10 mg kg^?1 IM), orotracheally intubated, connected to a pediatric circle breathing system, and allowed to spontaneously breathe isoflurane in oxygen. Once end‐tidal isoflurane concentration was stable at 1.4% for 15 minutes, endoscopy was started. A single endoscopist (REG), who was unaware of the treatment used, performed all endoscopies. The endoscopist scored the difficulty of endoscopy subjectively (0–3). The significance of differences between treatments was evaluated using Friedman's test. Time for entering the stomach was 9.4 (4.7–15.9) (median (minimum–maximum)), 6.6 (5.2–11.7), 8.4 (6.3–16.5), and 7.7 (5.1–14.7) seconds and for entering the duodenum from the stomach was 20.5 (13.8–40.9), 18.2 (10.3–39.8), 20.2 (16.2–119.5), and 22.2 (11.8–83.8) seconds for H, HG, M, and B treatments, respectively. There were no significant differences in the time for, or difficulty of, endoscopy. We conclude that any of these drugs can be used satisfactorily at the doses and combinations tested to pre‐medicate cats prior to general anesthesia for GD.     

Neurological diseases of ruminant livestock in Australia. II: toxic disorders and nutritional deficiencies

The second in this series of clinical reviews on neurological diseases in ruminant livestock in Australia examines toxic disorders associated with plant and microbial toxins as well as the neurological effects of vitamin and mineral deficiencies. The aim of these reviews is to assist in the surveillance of neurological diseases, especially the transmissible spongiform encephalopathies.     

Effects of a controlled-release albendazole capsule on parasitism and production from grazing Merino ewes and lambs

SUMMARY: Effects of a controlled-release albendazole capsule (CRC) on nematode parasitism and production of Merino ewes and lambs were Investigated in a replicated grazing experiment between August 1986 and July 1989. The experiment was conducted on a site where the naturally occurring parasites were benzimidazole-resistant, with double the recommended dose of oxfendazole reducing faecal egg counts of Trichostrongylus colubriformis by less than 50%. Two CRC treatments were compared with a minimal treatment control and the widely-used strategic control program, Wormkill.
Egg counts and worm burdens of major parasite species of ewes and of lambs before and after weaning were significantly reduced by use of the CRC in ewes before lambing or in lambs at weaning. These parasitological effects were reflected in increased productivity of CRC ewes and lambs. Ewes given CRCs lost less weight and grew more wool during lactation than ewes given Wormkill or control treatments, while their lambs gained more weight and had heavier fleeces than lambs from Wormkill or control treatments. Where lambs were weaned by removing ewes from the lambing paddock, administration of the CRC at weaning to lambs whose dams had also been treated with the CRC did not result in improved production when compared with lambs from ewes dosed with CRCs and treated after weaning according to the Wormkill program. Some possible uses for the CRC in ewes and lambs were identified.